Lorena Incorvaia

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma

Benjamin Bian, Daniele Fanale, Nelson Dusetti et al. · OncoImmunology · 2019 · 120 citations · Full text

Activin A circulating levels in patients with bone metastasis from breast or prostate cancer

Gaetano Leto, Lorena Incorvaia, Giuseppe Badalamenti et al. · Clinical & Experimental Metastasis · 2006 · 115 citations

Urology, Breast Oncology, Medicine +9

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 86 citations · Full text

Endocrine Oncology, Breast Oncology, Medicine +7

MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.

Lorena Incorvaia, Giuseppe Badalamenti, GiovamBattista Rini et al. · PubMed · 2007 · 82 citations

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti et al. · OncoImmunology · 2020 · 79 citations · Full text